Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Parkinson's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 163 articles:
HTML format
Text format



Single Articles


    March 2010
  1. LEWITT PA
    Relief of parkinsonism and dyskinesia. One and the same dopaminergic mechanism?
    Neurology. 2010.
    PubMed     Text format     Related articles   


  2. ZESIEWICZ TA , Sullivan KL, Arnulf I, Chaudhuri KR, et al
    Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology. 2010;74:924-31.
    PubMed     Text format     Related articles    Abstract available


  3. CHEN H , Huang X, Guo X, Mailman RB, et al
    Smoking duration, intensity, and risk of Parkinson disease.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. YUGETA A , Terao Y, Fukuda H, Hikosaka O, et al
    Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease.
    Neurology. 2010;74:743-8.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  5. KLEIN JC , Eggers C, Kalbe E, Weisenbach S, et al
    Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available


  6. KAUFMANN H , Goldstein DS
    Pure autonomic failure: A restricted Lewy body synucleinopathy or early Parkinson disease?
    Neurology. 2010;74:536-7.
    PubMed     Text format     Related articles   


    January 2010
  7. GOLDSTEIN DS , Sewell L, Holmes C
    Association of anosmia with autonomic failure in Parkinson disease.
    Neurology. 2010;74:245-51.
    PubMed     Text format     Related articles    Abstract available


  8. POSTUMA RB , Gagnon JF, Rompre S, Montplaisir JY, et al
    Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease.
    Neurology. 2010;74:239-44.
    PubMed     Text format     Related articles    Abstract available


  9. BURACK MA , Hartlein J, Flores HP, Taylor-Reinwald L, et al
    In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.
    Neurology. 2010;74:77-84.
    PubMed     Text format     Related articles    Abstract available


  10. CHANSAKUL C , Teleb M, Bomprezzi R
    Palmocervical reflex: a hyperactive palmomental reflex?
    Neurology. 2010;74:91.
    PubMed     Text format     Related articles   


    December 2009
  11. ROE CM , Fitzpatrick AL, Xiong C, Sieh W, et al
    Cancer linked to Alzheimer disease but not vascular dementia.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  12. UC EY , Rizzo M, Johnson AM, Dastrup E, et al
    Road safety in drivers with Parkinson disease.
    Neurology. 2009;73:2112-9.
    PubMed     Text format     Related articles    Abstract available


  13. BURKE WJ
    Mao-B inhibitor know-how: back to the pharm.
    Neurology. 2009;73:2048.
    PubMed     Text format     Related articles   


    November 2009
  14. SAVICA R , Carlin JM, Grossardt BR, Bower JH, et al
    Medical records documentation of constipation preceding Parkinson disease: A case-control study.
    Neurology. 2009;73:1752-1758.
    PubMed     Text format     Related articles    Abstract available


  15. LE JEUNE F , Drapier D, Bourguignon A, Peron J, et al
    Subthalamic nucleus stimulation in Parkinson disease induces apathy: A PET study.
    Neurology. 2009;73:1746-1751.
    PubMed     Text format     Related articles    Abstract available


  16. HOOPS S , Nazem S, Siderowf AD, Duda JE, et al
    Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
    Neurology. 2009;73:1738-1745.
    PubMed     Text format     Related articles    Abstract available


  17. BOHNEN NI , Muller ML, Koeppe RA, Studenski SA, et al
    History of falls in Parkinson disease is associated with reduced cholinergic activity.
    Neurology. 2009;73:1670-6.
    PubMed     Text format     Related articles    Abstract available


  18. BENARROCH EE
    The locus ceruleus norepinephrine system: functional organization and potential clinical significance.
    Neurology. 2009;73:1699-704.
    PubMed     Text format     Related articles   


  19. MARTINEZ-MARTIN P , Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, et al
    International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease.
    Neurology. 2009;73:1584-91.
    PubMed     Text format     Related articles    Abstract available


  20. UC EY , McDermott MP, Marder KS, Anderson SW, et al
    Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.
    Neurology. 2009;73:1469-77.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  21. SIDRANSKY E , Samaddar T, Tayebi N
    Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.
    Neurology. 2009;73:1424-5.
    PubMed     Text format     Related articles   


  22. SAVICA R , Grossardt BR, Carlin JM, Icen M, et al
    Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.
    Neurology. 2009;73:1381-7.
    PubMed     Text format     Related articles    Abstract available


  23. GAO X , Simon KC, Han J, Schwarzschild MA, et al
    Family history of melanoma and Parkinson disease risk.
    Neurology. 2009;73:1286-91.
    PubMed     Text format     Related articles    Abstract available


  24. CHRISTINE CW , Starr PA, Larson PS, Eberling JL, et al
    Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  25. CLAASSEN DO , Boes CJ
    Rosenow's rabbits and postencephalitic parkinsonism.
    Neurology. 2009;73:1240-1.
    PubMed     Text format     Related articles   


  26. PFEIFFER RF
    Neuroinflammation and Parkinson disease. The silent battleground.
    Neurology. 2009.
    PubMed     Text format     Related articles   


  27. UC EY , Rizzo M, Anderson SW, Dastrup E, et al
    Driving under low-contrast visibility conditions in Parkinson disease.
    Neurology. 2009;73:1103-10.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  28. RUGBJERG K , Friis S, Ritz B, Schernhammer ES, et al
    Autoimmune disease and risk for Parkinson disease. A population-based case-control study.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  29. FARAG ES , Vinters HV, Bronstein J
    Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  30. LIPTON J , Rivkin MJ
    16p11.2-related paroxysmal kinesigenic dyskinesia and dopa-responsive parkinsonism in a child.
    Neurology. 2009;73:479-80.
    PubMed     Text format     Related articles   


  31. GOETZ CG
    Jean-Martin Charcot and his vibratory chair for Parkinson disease.
    Neurology. 2009;73:475-8.
    PubMed     Text format     Related articles    Abstract available


  32. TISCH S , Brew B
    Parkinsonism in hiv-infected patients on highly active antiretroviral therapy.
    Neurology. 2009;73:401-3.
    PubMed     Text format     Related articles   


  33. ANSELM IA , Sweadner KJ, Gollamudi S, Ozelius LJ, et al
    Rapid-onset dystonia-parkinsonism in a child with a novel atp1a3 gene mutation.
    Neurology. 2009;73:400-1.
    PubMed     Text format     Related articles   


  34. POULOPOULOS M , Silvers D
    Clinical reasoning: a video analysis of eye and limb movement abnormalities in a Parkinsonian syndrome.
    Neurology. 2009;73:e20-3.
    PubMed     Text format     Related articles   


    July 2009
  35. ROBOTTOM BJ , Weiner WJ, Asmus F, Huber H, et al
    Kick and rush: paradoxical kinesia in Parkinson disease.
    Neurology. 2009;73:328.
    PubMed     Text format     Related articles   


  36. MONTGOMERY EB JR , Hilker R
    Stn-dbs activates the target area in Parkinson disease.
    Neurology. 2009;73:327.
    PubMed     Text format     Related articles   


  37. PANKRATZ N , Kissell DK, Pauciulo MW, Halter CA, et al
    Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.
    Neurology. 2009;73:279-86.
    PubMed     Text format     Related articles    Abstract available


  38. RAJPUT AH , Voll A, Rajput ML, Robinson CA, et al
    Course in Parkinson disease subtypes: A 39-year clinicopathologic study.
    Neurology. 2009;73:206-12.
    PubMed     Text format     Related articles    Abstract available


  39. DORSEY ER , Thompson JP, Dayoub EJ, George B, et al
    Selegiline shortage: Causes and costs of a generic drug shortage.
    Neurology. 2009;73:213-7.
    PubMed     Text format     Related articles    Abstract available


  40. ESSELINK RA , de Bie RM, de Haan RJ, Lenders MW, et al
    Long-term superiority of subthalamic nucleus stimulation over pallidotomy in Parkinson disease.
    Neurology. 2009;73:151-3.
    PubMed     Text format     Related articles   


  41. KOCH G , Brusa L, Carrillo F, Lo Gerfo E, et al
    Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.
    Neurology. 2009;73:113-9.
    PubMed     Text format     Related articles    Abstract available


  42. AKAOGI Y , Asahina M, Yamanaka Y, Koyama Y, et al
    Sudomotor, skin vasomotor, and cardiovascular reflexes in 3 clinical forms of Lewy body disease.
    Neurology. 2009;73:59-65.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  43. BOHNEN NI , Albin RL
    Cholinergic denervation occurs early in Parkinson disease.
    Neurology. 2009.
    PubMed     Text format     Related articles   


  44. MONTGOMERY EB JR
    Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough.
    Neurology. 2009;72:2137.
    PubMed     Text format     Related articles   


  45. VILARINO-GUELL C , Wider C, Soto-Ortolaza AI, Cobb SA, et al
    Characterization of DCTN1 genetic variability in neurodegeneration.
    Neurology. 2009;72:2024-8.
    PubMed     Text format     Related articles    Abstract available


  46. CLARK LN
    Variation on a theme: identifying sequence variation in disease genes and defining pathogenicity.
    Neurology. 2009;72:1882-3.
    PubMed     Text format     Related articles   


    May 2009
  47. SHIMADA H , Hirano S, Shinotoh H, Aotsuka A, et al
    Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  48. OLANOW CW , Stern MB, Sethi K
    The scientific and clinical basis for the treatment of Parkinson disease (2009).
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  49. DONKER KAAT L , Boon AJ, Azmani A, Kamphorst W, et al
    Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  50. MARTINEZ-TORRES I , Hariz MI, Zrinzo L, Foltynie T, et al
    Improvement of tics after subthalamic nucleus deep brain stimulation.
    Neurology. 2009;72:1787-9.
    PubMed     Text format     Related articles   


  51. SILVEIRA-MORIYAMA L , Mathias C, Mason L, Best C, et al
    Hyposmia in pure autonomic failure.
    Neurology. 2009;72:1677-81.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  52. BAIN PG
    Dystonic tremor presenting as parkinsonism: long-term follow-up of SWEDDs.
    Neurology. 2009;72:1443-5.
    PubMed     Text format     Related articles   


  53. KIM JY , Kim SY, Kim JM, Kim YK, et al
    Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism.
    Neurology. 2009;72:1385-9.
    PubMed     Text format     Related articles    Abstract available


  54. SNYDER LR , Cruz-Aguado R, Sadilek M, Galasko D, et al
    Lack of cerebral bmaa in human cerebral cortex.
    Neurology. 2009;72:1360-1.
    PubMed     Text format     Related articles   


  55. LEWITT PA
    MAO-B inhibitor know-how: back to the pharm.
    Neurology. 2009;72:1352-7.
    PubMed     Text format     Related articles   


  56. POSTUMA RB , Gagnon JF, Vendette M, Fantini ML, et al
    Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.
    Neurology. 2009;72:1296-300.
    PubMed     Text format     Related articles    Abstract available


  57. VINGERHOETS FJ
    Dyskinesia in Parkinson disease: back for the future?
    Neurology. 2009;72:1202-3.
    PubMed     Text format     Related articles   


    March 2009
  58. NICHOLS WC , Kissell DK, Pankratz N, Pauciulo MW, et al
    Variation in GIGYF2 is not associated with Parkinson disease.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  59. MASCITELLI L , Pezzetta F, Goldstein MR
    Re: Total cholesterol and the risk of Parkinson disease.
    Neurology. 2009;72:860.
    PubMed     Text format     Related articles   


  60. CHU J , Wagle-Shukla A, Gunraj C, Lang AE, et al
    Impaired presynaptic inhibition in the motor cortex in Parkinson disease.
    Neurology. 2009;72:842-9.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  61. BROZOVA H , Barnaure I, Alterman RL, Tagliati M, et al
    STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
    Neurology. 2009;72:770.
    PubMed     Text format     Related articles   


  62. WATANABE H , Hirayama M, Noda A, Ito M, et al
    B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist.
    Neurology. 2009;72:621-6.
    PubMed     Text format     Related articles    Abstract available


  63. TOLOSA E , Poewe W
    Premotor Parkinson disease.
    Neurology. 2009;72.
    PubMed     Text format     Related articles   


  64. POEWE W
    Treatments for Parkinson disease--past achievements and current clinical needs.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  65. OLANOW CW
    Can we achieve neuroprotection with currently available anti-parkinsonian interventions?
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  66. RASCOL O
    "Disease-modification" trials in Parkinson disease: target populations, endpoints and study design.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  67. SCHAPIRA AH
    Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  68. LANG AE
    When and how should treatment be started in Parkinson disease?
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  69. BROTCHIE J , Fitzer-Attas C
    Mechanisms compensating for dopamine loss in early Parkinson disease.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  70. GASSER T
    Genomic and proteomic biomarkers for Parkinson disease.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  71. MAREK K , Jennings D
    Can we image premotor Parkinson disease?
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  72. LEES AJ
    The Parkinson chimera.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  73. TOLOSA E , Gaig C, Santamaria J, Compta Y, et al
    Diagnosis and the premotor phase of Parkinson disease.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available


  74. BAIN PG , Lang A, Marras C
    Changing concepts in Parkinson disease: moving beyond the decade of the brain.
    Neurology. 2009;72:579.
    PubMed     Text format     Related articles   


  75. ASCHERIO A , Tanner CM
    Use of antihypertensives and the risk of Parkinson disease.
    Neurology. 2009;72:578-9.
    PubMed     Text format     Related articles   


  76. OUDIETTE D , De Cock VC, Lavault S, Leu S, et al
    Nonviolent elaborate behaviors may also occur in REM sleep behavior disorder.
    Neurology. 2009;72:551-7.
    PubMed     Text format     Related articles    Abstract available


  77. DRIVER JA , Logroscino G, Gaziano JM, Kurth T, et al
    Incidence and remaining lifetime risk of Parkinson disease in advanced age.
    Neurology. 2009;72:432-8.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  78. BRUCE BB , Biousse V, Newman NJ
    Re: Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology. 2009;72:382.
    PubMed     Text format     Related articles   


  79. FRIEDMAN JH
    Re: Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology. 2009;72:382.
    PubMed     Text format     Related articles   


  80. BRITTON TC , Chaudhuri KR
    REM-sleep behavior disorder and the risk of developing Parkinson disease or dementia.
    Neurology. 2009.
    PubMed     Text format     Related articles   


  81. LOHMANN E , Thobois S, Lesage S, Broussolle E, et al
    A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
    Neurology. 2009;72:110-6.
    PubMed     Text format     Related articles    Abstract available


  82. VAILLANCOURT DE , Spraker MB, Prodoehl J, Abraham I, et al
    High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available


  83. LANG AE , Mikulis D
    A new sensitive imaging biomarker for Parkinson disease?
    Neurology. 2009.
    PubMed     Text format     Related articles   


  84. KALBE E , Voges J, Weber T, Haarer M, et al
    Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
    Neurology. 2009;72:42-9.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  85. MENZA M , Defronzo Dobkin R, Marin H, Mark MH, et al
    A controlled trial of antidepressants in patients with Parkinson disease and depression.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  86. OKUN MS , Fernandez HH
    Will tricyclic antidepressants make a comeback for depressed Parkinson disease patients?
    Neurology. 2008.
    PubMed     Text format     Related articles   


  87. ABE K , Friedman Melissa Amick Kelvin Chou JH
    Rhinorrhea and olfaction in Parkinson disease.
    Neurology. 2008;71:1929.
    PubMed     Text format     Related articles   


  88. VERBAAN D , Boesveldt S, van Rooden SM, Visser M, et al
    Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?
    Neurology. 2008;71:1877-82.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  89. DI FONZO A , Dekker MC, Montagna P, Baruzzi A, et al
    FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  90. NANDHAGOPAL R , Mak E, Schulzer M, McKenzie J, et al
    Progression of dopaminergic dysfunction in a LRRK2 kindred: A multitracer PET study.
    Neurology. 2008;71:1790-5.
    PubMed     Text format     Related articles    Abstract available


  91. KARCESKI S
    Patient page. Progressive supranuclear palsy.
    Neurology. 2008;71:e70-2.
    PubMed     Text format     Related articles   


  92. BORRONI B , Malinverno M, Gardoni F, Alberici A, et al
    Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Neurology. 2008;71:1796-803.
    PubMed     Text format     Related articles    Abstract available


  93. AARSLAND D , Bronnick K, Larsen JP, Tysnes OB, et al
    Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  94. TROIANO AR , de la Fuente-Fernandez R, Sossi V, Schulzer M, et al
    PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  95. LIN CH , Tan EK, Chen ML, Tan LC, et al
    Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore.
    Neurology. 2008;71:1727-32.
    PubMed     Text format     Related articles    Abstract available


  96. TARSY D , Simon DK
    Beating a dead horse: dopamine and Parkinson disease.
    Neurology. 2008;71:1651.
    PubMed     Text format     Related articles   


  97. STRONGOSKY AJ , Farrer M, Wszolek ZK
    Are Parkinson disease patients protected from some but not all cancers?
    Neurology. 2008;71:1650.
    PubMed     Text format     Related articles   


  98. NICHOLS WC , Pankratz N, Marek DK, Pauciulo MW, et al
    Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  99. KLEIN C , Lohmann K
    Parkinson disease(s). Is "Parkin disease" a distinct clinical entity?
    Neurology. 2008.
    PubMed     Text format     Related articles   


  100. LESAGE S , Belarbi S, Troiano A, Condroyer C, et al
    Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?
    Neurology. 2008;71:1550-2.
    PubMed     Text format     Related articles   


    October 2008
  101. TROIANO AR , Cazeneuve C, Le Ber I, Bonnet AM, et al
    Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Neurology. 2008;71:1295.
    PubMed     Text format     Related articles   


  102. BRUEGGEMANN N , Odin P, Gruenewald A, Tadic V, et al
    Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.
    Neurology. 2008;71:1294.
    PubMed     Text format     Related articles   


  103. NUYTEMANS K , Pals P, Sleegers K, Engelborghs S, et al
    Progranulin variability has no major role in Parkinson disease genetic etiology.
    Neurology. 2008;71:1147-51.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  104. LANDIS BN , Burkhard PR
    Rhinorrhea and olfaction in Parkinson disease.
    Neurology. 2008;71:1041-2.
    PubMed     Text format     Related articles   


  105. SILVEIRA-MORIYAMA L , Guedes LC, Kingsbury A, Ayling H, et al
    Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.
    Neurology. 2008;71:1021-6.
    PubMed     Text format     Related articles    Abstract available


  106. BENNINGER D , Waldvogel D, Bassetti CL
    REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
    Neurology. 2008;71:955.
    PubMed     Text format     Related articles   


  107. GOMPERTS SN , Rentz DM, Moran E, Becker JA, et al
    Imaging amyloid deposition in Lewy body diseases.
    Neurology. 2008;71:903-10.
    PubMed     Text format     Related articles    Abstract available


  108. MARTIN WR , Wieler M
    Subthalamic nucleus stimulation in Parkinson disease: exciting or depressing?
    Neurology. 2008;71:704-5.
    PubMed     Text format     Related articles   


    August 2008
  109. ASMUS F , Huber H, Gasser T, Schols L, et al
    Kick and rush: paradoxical kinesia in Parkinson disease.
    Neurology. 2008;71:695.
    PubMed     Text format     Related articles   


  110. DIEDERICH NJ , Goetz CG
    The placebo treatments in neurosciences: New insights from clinical and neuroimaging studies.
    Neurology. 2008;71:677-84.
    PubMed     Text format     Related articles    Abstract available


  111. SCHIFITTO G , Friedman JH, Oakes D, Shulman L, et al
    Fatigue in levodopa-naive subjects with Parkinson disease.
    Neurology. 2008;71:481-5.
    PubMed     Text format     Related articles    Abstract available


  112. WEINER WJ , Reich SG
    Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough.
    Neurology. 2008;71:470-1.
    PubMed     Text format     Related articles   


  113. KATZENSCHLAGER R , Head J, Schrag A, Ben-Shlomo Y, et al
    Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.
    Neurology. 2008;71:474-80.
    PubMed     Text format     Related articles    Abstract available


  114. ISHIHARA-PAUL L , Hulihan MM, Kachergus J, Upmanyu R, et al
    PINK1 mutations and parkinsonism.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  115. WANG LH , Johnson EM Jr
    Mixed lineage kinase inhibitor cep- 1347 fails to delay disability in early Parkinson disease.
    Neurology. 2008;71:462.
    PubMed     Text format     Related articles   


  116. TURNER MR , Matthews L, Ebers GC, Elkind MS, et al
    Teaching video NeuroImage: the "Fonzarelli" sign: focal thumb dystonia as an early manifestation of Parkinson disease.
    Neurology. 2008;71:e11.
    PubMed     Text format     Related articles   


    July 2008
  117. HILKER R , Voges J, Weber T, Kracht LW, et al
    STN-DBS activates the target area in Parkinson disease.
    Neurology. 2008.
    PubMed     Text format     Related articles    Abstract available


  118. ROSS OA , Toft M, Haugarvoll K
    Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutations.
    Neurology. 2008;71:303.
    PubMed     Text format     Related articles   


  119. VILARINO-GUELL C , Soto AI, Young JE, Lin SC, et al
    Susceptibility genes for restless legs syndrome are not associated with Parkinson disease.
    Neurology. 2008;71:222-3.
    PubMed     Text format     Related articles   


  120. TAGLIATI M
    Fine-tuning gait in Parkinson disease.
    Neurology. 2008;71:76-7.
    PubMed     Text format     Related articles   


  121. SCHLESINGER I , Schlesinger N
    Re: Gout and risk of Parkinson disease: a prospective study.
    Neurology. 2008;71:70.
    PubMed     Text format     Related articles   


  122. IWASAKI Y , Kano O, Ikeda K
    Re: Gout and risk of Parkinson disease: a prospective study.
    Neurology. 2008;71:70.
    PubMed     Text format     Related articles   


  123. SINGLETON A , Morris H
    Association, expression, pathobiology: is too much tau in PD a blueprint for genetic association?
    Neurology. 2008;71:11-2.
    PubMed     Text format     Related articles   


    June 2008
  124. BONIFATI V , Wu-Chou YH, Schweiger D, Fonzo AD, et al
    Re: LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Neurology. 2008;70:2348.
    PubMed     Text format     Related articles   


  125. ROGAEVA E , Hardy J
    Gaucher and Parkinson diseases: unexpectedly related.
    Neurology. 2008;70:2272-3.
    PubMed     Text format     Related articles   


  126. BRENNER SR
    Re: Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Neurology. 2008;70:2265.
    PubMed     Text format     Related articles   


  127. MUSLIMOVIC D , Post B, Speelman JD, Schmand B, et al
    Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Neurology. 2008;70:2241-7.
    PubMed     Text format     Related articles    Abstract available


  128. STACY M , Silver D, Mendis T, Sutton J, et al
    A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease.
    Neurology. 2008;70:2233-40.
    PubMed     Text format     Related articles    Abstract available


    May 2008
  129. TOBIN JE , Latourelle JC, Lew MF, Klein C, et al
    Haplotypes and gene expression implicate the MAPT region for Parkinson disease. The GenePD Study.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  130. BURKE WJ
    Beating a dead horse: dopamine and Parkinson disease.
    Neurology. 2008;70:2087.
    PubMed     Text format     Related articles   


  131. MARRAS C , Lang A
    Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain.
    Neurology. 2008;70:1996-2003.
    PubMed     Text format     Related articles    Abstract available


  132. BENARROCH EE
    Subthalamic nucleus and its connections: Anatomic substrate for the network effects of deep brain stimulation.
    Neurology. 2008;70:1991-5.
    PubMed     Text format     Related articles   


  133. SHEEHY SH , Lawrence T, Thevathasan AW
    Serpentine tongue: A lingual dyskinesia.
    Neurology. 2008;70:e87.
    PubMed     Text format     Related articles   


  134. BRAAK H , Del Tredici K
    Invited Article: Nervous system pathology in sporadic Parkinson disease.
    Neurology. 2008;70:1916-25.
    PubMed     Text format     Related articles   


  135. ESPAY AJ
    Reversible parkinsonism and ataxia associated with high-dose octreotide.
    Neurology. 2008;.
    PubMed     Text format     Related articles   


    April 2008
  136. GAN-OR Z , Giladi N, Rozovski U, Shifrin C, et al
    Genotype--phenotype correlations between GBA mutations and Parkinson disease risk and onset.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  137. MOREAU C , Defebvre L, Destee A, Bleuse S, et al
    STN-DBS frequency effects on freezing of gait in advanced Parkinson disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  138. NING YP , Kanai K, Tomiyama H, Li Y, et al
    PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype.
    Neurology. 2008;70.
    PubMed     Text format     Related articles   


  139. GUEHL D , Vital A, Cuny E, Spampinato U, et al
    Postmortem proof of effectiveness of zona incerta stimulation in Parkinson disease.
    Neurology. 2008;70.
    PubMed     Text format     Related articles   


  140. NANDHAGOPAL R , McKeown MJ, Stoessl AJ
    Invited article: Functional imaging in Parkinson disease.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  141. POTTER M , Herzog J, Siebner HR, Kopper F, et al
    Subthalamic nucleus stimulation modulates audiospinal reactions in Parkinson disease.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  142. FERRAYE MU , Debu B, Fraix V, Xie-Brustolin J, et al
    Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  143. DRIVER JA , Kurth T, Buring JE, Gaziano JM, et al
    Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  144. KAWAI Y , Suenaga M, Takeda A, Ito M, et al
    Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.
    Neurology. 2008;70.
    PubMed     Text format     Related articles    Abstract available


  145. EBERLING JL , Jagust WJ, Christine CW, Starr P, et al
    Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  146. HU G , Antikainen R, Jousilahti P, Kivipelto M, et al
    Total cholesterol and the risk of Parkinson disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  147. PAPAPETROPOULOS S , Jagid JR, Sengun C, Singer C, et al
    Objective monitoring of tremor and bradykinesia during DBS surgery for Parkinson disease.
    Neurology. 2008;70:1244-9.
    PubMed     Text format     Related articles    Abstract available


  148. MASSICOTTE-MARQUEZ J , Decary A, Gagnon JF, Vendette M, et al
    Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder.
    Neurology. 2008;70:1250-7.
    PubMed     Text format     Related articles    Abstract available


  149. MORO E , Volkmann J, Konig IR, Winkler S, et al
    Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
    Neurology. 2008;70:1186-91.
    PubMed     Text format     Related articles    Abstract available


    March 2008
  150. HUANG C , Mattis P, Perrine K, Brown N, et al
    Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  151. BUTER TC , van den Hout A, Matthews FE, Larsen JP, et al
    Dementia and survival in Parkinson disease: a 12-year population study.
    Neurology. 2008;70:1017-22.
    PubMed     Text format     Related articles    Abstract available


  152. ZACCAI J , Brayne C, McKeith I, Matthews F, et al
    Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Neurology. 2008;70:1042-8.
    PubMed     Text format     Related articles    Abstract available


  153. HAUGARVOLL K , Rademakers R, Kachergus JM, Nuytemans K, et al
    Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  154. BRIGHINA L , Frigerio R, Schneider NK, Lesnick TG, et al
    {alpha}-Synuclein, pesticides, and Parkinson disease. A case-control study.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


    February 2008
  155. KOMPOLITI K
    Diagnosis and management of Parkinson's disease.
    Neurology. 2008;70:739.
    PubMed     Text format     Related articles   


  156. ALVAREZ MV , Evidente VG
    Understanding drug-induced parkinsonism: Separating pearls from oy-sters.
    Neurology. 2008;70:e32-34.
    PubMed     Text format     Related articles   


  157. BECKER C , Jick SS, Meier CR
    Use of antihypertensives and the risk of Parkinson disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  158. FRIEDMAN JH , Amick MM, Chou KL
    Rhinorrhea and olfaction in Parkinson disease.
    Neurology. 2008;70:487-9.
    PubMed     Text format     Related articles   


  159. THURMAN DJ , Stevens JA, Rao JK
    Practice parameter: Assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology. 2008;70:473-9.
    PubMed     Text format     Related articles    Abstract available


    January 2008
  160. RANSMAYR GN , Holliger S, Schletterer K, Heidler H, et al
    Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease.
    Neurology. 2008;70:299-303.
    PubMed     Text format     Related articles    Abstract available


  161. OBI T , Nishioka K, Ross OA, Terada T, et al
    Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia.
    Neurology. 2008;70:238-41.
    PubMed     Text format     Related articles   


  162. WAHNER AD , Bronstein JM, Bordelon YM, Ritz B, et al
    Statin use and the risk of Parkinson disease.
    Neurology. 2008;.
    PubMed     Text format     Related articles    Abstract available


    October 2007
  163. FARRER MJ
    Lrrk2 in the limelight!
    Neurology. 2007;69:1732-3.
    PubMed     Text format     Related articles   


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: